Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Heska Corporation    HSKA

HESKA CORPORATION

(HSKA)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Heska Corporation
Heska Corporation sells veterinary diagnostic and specialty products. The Company operates through two segments: Core Companion Animal Health (CCA) and Other Vaccines, Pharmaceuticals and Products (OVP). The CCA segment includes, primarily for canine and feline use, blood testing instruments and supplies, digital imaging products, software and services, local and cloud-based data services, allergy testing and immunotherapy, and single use offerings, such as in-clinic diagnostic tests and heartworm preventive products. Its OVP segment includes private label vaccine and pharmaceutical production for cattle but also for other species, including equine, porcine, avian, feline and canine. All OVP products are sold by third parties under third-party labels. It focuses on supporting veterinarians in canine and feline healthcare space. It offers a line of veterinary blood testing and other instruments. It manufactures biological and pharmaceutical products for other animal health companies.

Number of employees : 386 people.
Sales per Business
20182019Delta
USD (in Million)%USD (in Million)%
Core Companion Animal108.9285.5%106.5786.9% -2.16%
Other Vaccines and Pharmaceuticals18.5214.5%16.0913.1% -13.12%
Sales per region
20182019Delta
USD (in Million)%USD (in Million)%
United States115.5490.7%108.4788.4% -6.12%
Europe6.004.7%8.296.8% +38.27%
Canada2.992.3%3.042.5% +1.67%
Other International2.922.3%2.862.3% -1.89%
Managers
NameAgeSinceTitle
Kevin S. Wilson462014President, Chief Executive Officer & Director
Scott W. Humphrey482018Chairman
Nancy Wisnewski, Dr.562019Chief Operating Officer & Executive Vice President
Catherine I. Grassman432019Chief Financial Officer & Executive Vice President
Glenn R. Frank--Vice President-Research & Development
Sharon J. Larson582018Independent Director
David E. Sveen, Dr.622013Independent Director
Bonnie J. Trowbridge722015Independent Director
Mark F. Furlong612019Independent Director
Stephen L. Davis612020Director
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 9,454,771 8,866,971 93.8% 0 0.0% 93.8%
Shareholders
NameEquities%
Fred Alger Management LLC 1,277,801 13.5%
Nine Ten Capital Management LLC 769,121 8.14%
The Vanguard Group, Inc. 537,480 5.69%
Neuberger Berman Investment Advisers LLC 482,317 5.11%
Park West Asset Management LLC 457,869 4.85%
Columbia Management Investment Advisers LLC 399,479 4.23%
Aberdeen Standard Investments, Inc. 330,009 3.49%
SSgA Funds Management, Inc. 299,852 3.18%
TimesSquare Capital Management LLC 297,105 3.15%
Ashford Capital Management, Inc. 290,417 3.08%
Company contact information
Heska Corp.
3760 Rocky Mountain Avenue
Loveland, CO 80538

Phone : +1.970.493.7272
Fax : +1.970.619.3003
Web : http://www.heska.com
Sector Medical Equipment, Supplies & Distribution
1st jan.Capitalization (M$)
HESKA CORPORATION30.29%1 182
ABBOTT LABORATORIES24.59%191 805
MEDTRONIC PLC0.22%152 480
STRYKER CORPORATION11.17%87 710
BECTON, DICKINSON AND COMPANY-13.65%68 111
HOYA CORPORATION33.11%49 894
IDEXX LABORATORIES, INC.76.53%39 322
BAXTER INTERNATIONAL INC.-9.03%38 858
ALIGN TECHNOLOGY, INC.72.48%37 950
SARTORIUS STEDIM BIOTECH105.15%33 382
COLOPLAST A/S12.73%31 802
ALCON INC.5.80%31 298
ZIMMER BIOMET HOLDINGS-0.37%30 909
DEXCOM, INC.46.15%30 698
TERUMO CORPORATION6.74%30 026
SYSMEX CORPORATION46.73%21 881
AMERISOURCEBERGEN CORPORATION21.38%21 060
WEST PHARMACEUTICAL SERVICES, INC.84.90%20 342
STRAUMANN HOLDING AG9.64%18 274
TELEFLEX INCORPORATED-1.43%17 823
BIOMÉRIEUX52.24%17 086